Guangzhou Key Laboratory of Environmental Pollution and Health Risk Assessment, Department of Preventive Medicine, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China.
Department of Epidemiology, College for Public Health and Social Justice, Saint Louis University, Saint Louis 63104, USA.
Sci Total Environ. 2017 Dec 31;607-608:1304-1312. doi: 10.1016/j.scitotenv.2017.07.124. Epub 2017 Jul 27.
Previous studies have demonstrated associations of perfluoroalkyl substances (PFASs), a group of highly persistent chemicals ubiquitous in wildlife and humans, with hypertension, but the relationships are mixed. Furthermore, academic literature on the relationship between isomers of PFASs and blood pressure (BP) and hypertension in populations from a higher pollution area is scant. We studied 1612 Chinese adults, ages 22-96years old, from Shenyang, China, utilizing high performance liquid chromatography-mass spectrometry to analyze isomers of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other PFASs in blood serum. We used a mercury sphygmomanometer to measure BP. Hypertension was defined as a mean systolic BP (SBP) of at least 140mmHg, and/or diastolic BP (DBP) of at least 90mmHg, and/or use of antihypertensive medications. The results showed that increased serum concentrations of all (both branched and linear) isomers of PFASs were associated with higher prevalence of hypertension. Adjusted odds ratios for hypertension per ln-unit (ng/mL) increase in PFASs ranged from 1.10 (95%CI: 1.04, 1.17) for perfluorobutanoic acid (PFBA) to 1.26 (95%CI: 1.12, 1.42) for 3+4+5m PFOS, and the estimated increases in mean SBP and DBP ranged from 0.80mmHg (95%CI: 0.25, 1.34) for PFBA to 4.51mmHg (95%CI: 3.52, 5.51) for 3+4+5m PFOS, and from 0.51mmHg (95%CI: 0.01, 1.01) for perfluorodecanesulfonate (PFDS) to 2.48 (1.80, 3.16) for perfluorononanoic acid (PFNA), respectively. Compared with linear PFASs isomers, we identified more and stronger associations among branched PFASs isomers and blood pressure. Furthermore, females exhibited consistently stronger effects than males. In conclusion, this study is the first of its kind to show that not only PFASs positively associated with elevated blood pressure, but also that branched PFAS isomers are more frequently associated with blood pressure than linear PFAS isomers.
先前的研究表明,全氟烷基物质(PFASs)与高血压有关,PFASs 是一种在野生动物和人类中普遍存在的高度持久的化学物质。然而,这些关系是混杂的。此外,关于来自污染程度更高地区的人群中 PFASs 异构体与血压(BP)和高血压之间关系的学术文献很少。我们研究了来自中国沈阳的 1612 名 22-96 岁的成年人,利用高效液相色谱-质谱法分析了血清中全氟辛烷磺酸(PFOS)、全氟辛酸(PFOA)和其他 PFASs 的异构体。我们使用汞柱式血压计测量血压。高血压定义为平均收缩压(SBP)至少 140mmHg,和/或舒张压(DBP)至少 90mmHg,和/或使用抗高血压药物。结果表明,所有(支链和直链)PFASs 异构体血清浓度的升高与高血压患病率的升高有关。PFASs 每 ln 单位(ng/mL)增加的高血压调整比值比(OR)范围从 1.10(95%CI:1.04,1.17)对于全氟丁烷酸(PFBA)到 1.26(95%CI:1.12,1.42)对于 3+4+5m PFOS,平均 SBP 和 DBP 的估计增加值范围从 0.80mmHg(95%CI:0.25,1.34)对于 PFBA 到 4.51mmHg(95%CI:3.52,5.51)对于 3+4+5m PFOS,从 0.51mmHg(95%CI:0.01,1.01)对于全氟癸烷磺酸(PFDS)到 2.48(1.80,3.16)对于全氟壬酸(PFNA),分别。与直链 PFASs 异构体相比,我们发现支链 PFASs 异构体与血压之间的关联更多且更强。此外,女性的作用始终强于男性。总之,这项研究是首例表明不仅 PFASs 与血压升高呈正相关,而且支链 PFASs 异构体与血压的相关性也强于直链 PFASs 异构体。